Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder - News-Medical.Net

Submitted by Anonymous (not verified) on Tue, 09/06/2022 - 17:47

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder  News-Medical.Net